Apexigen, Inc.
Apexigen, Inc. (APGN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · APGN · as of Jun 9, 2026
Key Statistics
Explore Apexigen, Inc. Data
apgn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
apgn competitorsAPGN
ALNA
AMTI
AXLA
BTHE
CHROStock Performance
Full HistoryAbout Apexigen, Inc.
Apexigen, Inc. Apexigen Inc., established in 2010 and based in San Carlos, California, is a clinical-stage biotechnology company dedicated to the discovery and advancement of antibody-based therapies for oncological…
what is apexigen, inc. · apgn stock overview · apexigen, inc. company profile · who is apexigen, inc. ceo · apgn NASDAQ · apexigen, inc. headquarters · apexigen, inc. business segments
About Stock Overview & Key Data
Apexigen, Inc. (APGN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 22, 2021. As of the latest trading session, APGN stock price is $0.39, with a market capitalization of $9.6M. The stock has returned -93.88% over the past 12 months and -40.75% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Apexigen, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2022, Apexigen, Inc. reported revenue of — and net income of -$31.5M. For detailed data — including Apexigen, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Apexigen, Inc. (APGN) stock price is $0.39. The stock is traded on NASDAQ under the ticker symbol APGN. The 52-week range is $0.33 – $8.28.